Cargando…

Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?()

The article describes the possible pathophysiological origin of COVID-19 and the crucial role of renin-angiotensin system (RAS), providing several “converging” evidence in support of this hypothesis. SARS-CoV-2 has been shown to initially upregulate ACE2 systemic activity (early phase), which can su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montanari, Mariele, Canonico, Barbara, Nordi, Evelyn, Vandini, Daniela, Barocci, Simone, Benedetti, Serena, Carlotti, Eugenio, Zamai, Loris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359569/ https://www.ncbi.nlm.nih.gov/pubmed/34419773 http://dx.doi.org/10.1016/j.jbior.2021.100820

Ejemplares similares

Circulating ACE2 level and zinc/albumin ratio as potential biomarkers for a precision medicine approach to COVID-19
por: Benedetti, Serena, et al.
Publicado: (2023)

Lock, Stock and Barrel: Role of Renin-Angiotensin-Aldosterone System in Coronavirus Disease 2019
por: Zanza, Christian, et al.
Publicado: (2021)

The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients
por: Zamai, Loris
Publicado: (2020)

Upregulation of the Renin–Angiotensin System Pathways and SARS-CoV-2 Infection: The Rationale for the Administration of Zinc-Chelating Agents in COVID-19 Patients
por: Zamai, Loris
Publicado: (2021)

Fluorescent Silica Nanoparticles Targeting Mitochondria: Trafficking in Myeloid Cells and Application as Doxorubicin Delivery System in Breast Cancer Cells
por: Sola, Federica, et al.
Publicado: (2022)

Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system?
por: Silhol, François, et al.
Publicado: (2020)

Role of Renin-Angiotensin-Aldosterone System and Cortisol in Endometriosis: A Preliminary Report
por: Sabbadin, Chiara, et al.
Publicado: (2022)

Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
por: Barocci, Simone, et al.
Publicado: (2022)

Comparing Heterologous and Homologous COVID-19 Vaccination: A Longitudinal Study of Antibody Decay
por: Orlandi, Chiara, et al.
Publicado: (2023)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

Intradialytic hypotension and cardiac remodeling: should we consider the renin-angiotensin-aldosterone system?
por: Wang, Juanli, et al.
Publicado: (2021)

Why and When Bacterial Vaccines Should Be Given
por: Wells, W. Frank
Publicado: (1913)

Effects of Dapagliflozin on Volume Status When Added to Renin–Angiotensin System Inhibitors
por: Eickhoff, Mie K., et al.
Publicado: (2019)

When and which patients should receive remdesivir?
por: Garcia-Vidal, Carolina, et al.
Publicado: (2022)

Investigations in West Syndrome: Which, When and Why
por: Appleton, Richard E.
Publicado: (2015)

Should we continue to use renin–angiotensin–aldosterone system blockers in patients with COVID-19?
por: Copur, Sidar, et al.
Publicado: (2022)

Should We Use Renin-Angiotensin-Aldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy?
por: Park, Jae-Hyeong
Publicado: (2023)

Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored
por: Zarbock, Alexander, et al.
Publicado: (2021)

The Renin-Angiotensin System Textbook
por: Cumming, Allan D
Publicado: (1994)

Brain renin angiotensin in disease
por: Phillips, M. Ian, et al.
Publicado: (2008)

Monocyte Response to Different Campylobacter jejuni Lysates Involves Endoplasmic Reticulum Stress and the Lysosomal–Mitochondrial Axis: When Cell Death Is Better Than Cell Survival
por: Canonico, Barbara, et al.
Publicado: (2018)

Plasma in the PICU: why and when should we transfuse?
por: Labarinas, Sonia, et al.
Publicado: (2013)

Pediatric enteral nutrition therapy for burn victims: when should it be initiated?
por: Valentini, Mariéle, et al.
Publicado: (2019)

Comparing bowel lengthening procedures: which, when, and why?
por: van Praagh, Jasper B., et al.
Publicado: (2022)

SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
por: Kuster, Gabriela M, et al.
Publicado: (2020)

Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System–Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System
por: Konoshita, Tadashi
Publicado: (2011)

Unveiling Human Non-Random Genome Editing Mechanisms Activated in Response to Chronic Environmental Changes: I. Where Might These Mechanisms Come from and What Might They Have Led To?
por: Zamai, Loris
Publicado: (2020)

The renin–angiotensin system and diabetes: An update
por: Ribeiro-Oliveira, Antônio, et al.
Publicado: (2008)

ANGIOTENSIN AND RENIN IN RAT AND DOG BRAIN
por: Fischer-Ferraro, Catalina, et al.
Publicado: (1971)

The renin-angiotensin system and aging in the kidney
por: Yoon, Hye Eun, et al.
Publicado: (2014)

Within the Brain: The Renin Angiotensin System
por: Jackson, LaDonya, et al.
Publicado: (2018)

Renin-Angiotensin System and Cardiovascular Functions
por: Wu, Chia-Hua, et al.
Publicado: (2018)

COVID-19 and the Renin-Angiotensin System
por: Malha, Line, et al.
Publicado: (2020)

Role of the Renin-Angiotensin System in ARDS
por: Zambelli, V., et al.
Publicado: (2012)

Effects of Statins on Renin–Angiotensin System
por: Kiaie, Nasim, et al.
Publicado: (2021)

Nanoparticle approaches for the renin-angiotensin system
por: Hettiarachchi, Sajini D., et al.
Publicado: (2023)

The Adipose Renin-Angiotensin System Modulates Systemic Markers of Insulin Sensitivity and Activates the Intrarenal Renin-Angiotensin System
por: Kim, Suyeon, et al.
Publicado: (2006)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors
por: Yong, Qian Chen, et al.
Publicado: (2013)

Overviews of Pathogen Emergence: Which Pathogens Emerge, When and Why?
por: Cleaveland, S., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ttnpn36i0a9aghiltl9em7ivg0